Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in invasive bladder cancer in clinical practice.

被引:0
|
作者
Mehler, Shoshana
Guilbeau, Seth
Somer, Shmuel
Reed, Kevin
Greene, Heather
Vaena, Daniel A.
Grothey, Axel
Somer, Brad
机构
[1] West Canc Ctr, Memphis, TN USA
[2] Univ Tennessee, Med Ctr, Knoxville, TN USA
[3] West Canc Ctr & Res Inst, Germantown, TN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
542
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in stage 1-3 colorectal cancer (CRC) in clinical practice
    Somer, B.
    Mehler, S.
    Hasenburg, A.
    Greene, H.
    Tauer, K.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S347 - S347
  • [2] A patient-specific, tumor-informed, circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) assay in surgical patients with biliary tract cancer
    Song, Tianqiang
    Wu, Qiang
    Cui, Yunlong
    Li, Huikai
    Zhang, Wei
    Fang, Feng
    Xiong, Qingqing
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Enhanced detection of molecular residual disease (MRD) by tumor-informed and tumor-agnostic variants in circulating tumor DNA (ctDNA)
    Yan, Xiaoluan
    Li, Zhencong
    Wang, YanYan
    Li, Juan
    Liu, Ming
    Wang, Hongwei
    Jin, Kemin
    Bao, Quan
    Wang, Lijun
    Liu, Wei
    Liu, Lijuan
    Da, Xu
    Hu, Yifan
    Zhang, Yiqun
    Zang, Yuehua
    Pei, Zhihua
    Wang, Dongliang
    Zhou, Qiming
    Xing, Baocai
    Wang, Kun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Analytical and clinical validation of a personalized, tumor-informed circulating tumor DNA assay for minimal residual disease detection
    Yang, Zuoquan
    Zhou, Yanqing
    Chen, Yaru
    Teng, Jiaman
    An, Heng
    Cheng, Shaochen
    Xu, Mingyan
    Chen, Shifu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer
    Emiloju, Oluwadunni E.
    Storandt, Michael
    Zemla, Tyler
    Tran, Nguyen
    Jethwa, Krishan
    Mahipal, Amit
    Mitchell, Jessica
    Thiels, Cornelius
    Mathis, Kellie
    McWilliams, Robert
    Hubbard, Joleen
    Sinicrope, Frank
    Shi, Qian
    Jin, Zhaohui
    JCO PRECISION ONCOLOGY, 2024, 8
  • [6] Clinical experience of a personalized and tumor-informed circulating tumor DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients
    Cohen, S.
    Hook, N.
    Krinshpun, S.
    Westbrook, L.
    Loranger, K.
    Wallace, J.
    Aleshin, A.
    Billings, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S229 - S229
  • [7] Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer
    Gong, Jun
    Hendifar, Andrew
    Gangi, Alexandra
    Zaghiyan, Karen
    Atkins, Katelyn
    Nasseri, Yosef
    Murrell, Zuri
    Figueiredo, Jane C.
    Salvy, Sarah
    Haile, Robert
    Hitchins, Megan
    CANCERS, 2021, 13 (18)
  • [8] Feasibility of tumor-informed circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment in pediatric patients with solid tumors.
    Mitchell, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysis
    Kommalapati, Ajitha
    Laliotis, George
    Glover, Michael
    Selig, Grayce
    Kollipara, Revathi
    Mahmood, Tamara
    Shah, Sumit
    Hoimes, Christopher J.
    Stewart, Tyler F.
    Sharma, Shruti
    Malhotra, Meenakshi
    Pajak, Natalia
    Calhoun, Mark
    ElNaggar, Adam
    Liu, Minetta C.
    Basu, Arnab
    Galsky, Matt D.
    Tan, Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] A tumor-informed, hybrid-capture based ctDNA assay for minimal residual disease (MRD) detection in colorectal cancer (CRC) patients after curative surgery
    Han, S-W.
    Heo, S.
    Lim, Y.
    Lee, W.
    Kim, H-P.
    Kim, S. Y.
    Bang, D.
    Park, K. J.
    Oh, S. T.
    Yoo, C. S.
    Kang, S-B.
    Kim, Y-J.
    Kim, T-Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S710 - S711